NCT07628296 Non-Invasive Blood Pressure Accuracy Study for Adult Subject Populations
| NCT ID | NCT07628296 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GE Healthcare |
| Condition | Blood Pressure |
| Study Type | INTERVENTIONAL |
| Enrollment | 130 participants |
| Start Date | 2025-01-13 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 130 participants in total. It began in 2025-01-13 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to collect NIBP and invasive aortic pressure data from the clinical setting.
Eligibility Criteria
Inclusion Criteria: 1. Age requirement: 18 and over. 2. Have an upper limb (right OR left side) that fits the cuff size of the device (circumference ranging 17 cm to 40 cm) OR have a thigh (right OR left side) that fits a cuff size of the device (circumference ranging 38 to 50 cm). 3. Have an arterial line as a standard of care, which measures blood pressure at the aortic root. 4. Able to provide written informed consent. 5. Expected to remain in the unit for the duration of the study procedure. Exclusion Criteria: 1. Have previously participated in this study (no subject may participate more than once). 2. Pregnant and lactating women per site standard of care. 3. Subjects with peripheral arterial diseases (causing left/right arm difference) 4. Hemodynamically unstable subjects at the discretion of the investigator. 5. Exhibited injuries, deformities, intravenous lines, or other abnormalities that, in the opinion of the Investigator, may prevent proper cuff application or functioning. 6. Are suffering from infection(s) or immunocompromised patients that require isolation. 7. PI or designee decision due to subject health conditions
Frequently Asked Questions
Who can join the NCT07628296 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Blood Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07628296 currently recruiting?
Yes, NCT07628296 is actively recruiting participants. Visit ClinicalTrials.gov or contact GE Healthcare to inquire about joining.
Where is the NCT07628296 trial being conducted?
This trial is being conducted at Helsinki, Finland.
Who is sponsoring the NCT07628296 clinical trial?
NCT07628296 is sponsored by GE Healthcare. The trial plans to enroll 130 participants.